NCT04856488View on ClinicalTrials.gov

Preoperative Lugol's Solution in Graves' Disease and Toxic Nodular Goiter

PHASE3RecruitingINTERVENTIONAL
Enrollment

182

Participants

Timeline

Start Date

November 18, 2021

Primary Completion Date

August 31, 2025

Study Completion Date

August 31, 2025

Conditions
Hyperthyroidism
Interventions
DRUG

Iodine-Potassium Iodide 5%-10% Oral and Topical Solution

Iodine Potassium Iodide 5% oral solution, administered 3 times per day for 10 days

Trial Locations (1)

17176

RECRUITING

Department of Endocrinology, Karolinska University Hospital, Solna

All Listed Sponsors
lead

Jan Calissendorff

OTHER